Detection of glucocorticoid receptor (GR) expression in circulating tumor cells (CTCs) from patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Wise, David
Louw, Jessica
Krupa, Rachel
Schreiber, Nicole A.
Sawyers, Charles L.
Dittamore, Ryan Vance
Scher, Howard I.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5046
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Cabazitaxel for octogenarian patients with metastatic castration-resistant prostate cancer (MCRPC)
    Tralongo, P.
    Bordonaro, S.
    Di Lorenzo, G.
    Borsellino, N.
    Facchini, G.
    Rossetti, S.
    Martelli, V.
    Longo, V.
    Tralongo, A. C.
    Caspani, F.
    Tuzi, A.
    Spada, M.
    Calvani, N.
    Carlini, P.
    De Giorgi, U. F. F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [42] Circulating tumor DNA (ctDNA) and correlations with clinical prognostic factors in patients with metastatic castration-resistant prostate cancer (mCRPC).
    Khalaf, Daniel
    Annala, Matti
    Beja, Kevin
    Vandekerkhove, Gillian
    Zulfiqar, Muhammad
    Finch, Daygen L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [43] Characterization of SLFN11 protein expression in circulating tumor cells (CTCs) of patients with metastatic castration resistant prostate cancer (mCRPC) prior to platinum based chemotherapy
    Fernandez, Luisa
    Poirier, John
    Rodriguez, Angel
    Hulling, Melanie
    Richardson, Robin
    Sutton, Ramsay
    Jiles, Rhett
    Schonhoft, Joseph
    Lee, Jerry
    Ebrahim, Nadia
    Carbone, Emily
    Barnett, Ethan
    Landers, Mark
    Wang, Yipeng
    Dittamore, Ryan
    Rudin, Charles
    Scher, Howard
    CANCER RESEARCH, 2019, 79 (13)
  • [44] Phenotypic, genomic, and clinical associations of Circulating Tumor Cells (CTCs) lacking epithelial biomarkers in metastatic Castration Resistant Prostate Cancer (mCRPC)
    Graf, Ryon P.
    Wang, Yipeng
    Schreiber, Nicole
    McLaughlin, Brigit
    Greene, Stephanie
    Rodriguez, Angel
    Jendrisak, Adam
    Lee, Jerry
    Landers, Mark
    Dittamore, Ryan
    Scher, Howard I.
    CANCER RESEARCH, 2017, 77
  • [45] Expression of prostate-specific membrane antigen (PSMA) on circulating tumor cells (CTCs) in castration-resistant prostate cancer.
    Lee, Florence
    Yu, Angela
    Anderson, Amanda
    Marrinucci, Dena
    Magargal, Wells W.
    DiPippo, Vincent A.
    Olson, William C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [46] Clinical significance of AR mRNA quantification from circulating tumor cells (CTCs) in men with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone (Abi) or enzalutamide (Enza).
    Silberstein, John
    Luber, Brandon
    Wang, Hao
    Lu, Changxue
    Chen, Yan
    Zhu, Yezi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [47] Prognosis of metastatic castration-resistant prostate cancer in response to chemotherapy and PSMA expression in circulating tumor cells
    Nagaya, N.
    Nagata, M.
    Ashizawa, T.
    Lu, Y.
    Fujita, K.
    Horie, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1579 - S1580
  • [48] Chromosomal instability (CIN) in circulating tumor cells (CTC) predicts for taxane sensitivity in metastatic castration-resistant prostate cancer (mCRPC).
    Keegan, Niamh M.
    Arfe, Andrea
    Barnett, Ethan
    Cohn, Erica Dayan
    Zhao, Jimmy
    Carbone, Emily
    Zanone, Michelle
    Anderson, Amanda
    Wenstrup, Rick
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Circulating tumor DNA fraction (ctDNA) as a surrogate predictive biomarker in metastatic castration-resistant prostate cancer (mCRPC).
    Conteduca, Vincenza
    Wetterskog, Daniel
    Scarpi, Emanuela
    Romanel, Alessandro
    Gurioli, Giorgia
    Jayaram, Anuradha
    Lolli, Cristian
    Schepisi, Giuseppe
    Casadei, Chiara
    Menna, Cecilia
    Wingate, Anna
    Demichelis, Francesca
    De Giorgi, Ugo
    Attard, Gerhardt
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Real-world patterns of genomic testing in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Shore, N.
    Ionescu-Ittu, R.
    Yang, L.
    Laliberte, F.
    Payne, S.
    Gayle, A.
    Amin, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S526 - S527
12345